Sunshine Lake Pharma Co Ltd
1 products tracked · names used in filings: Sunshine Lake Pharma Co Ltd
Upcoming milestones
No upcoming milestones listed.
Recent milestones
Wed 29 Apr 2026🇺🇸 FDA approval
FDA approves biosimilar Langlara (insulin glargine-aldy)
Sunshine Lake Pharma Co Ltd; BLA761412; Biosimilar; injectable · source
Products
| Product | Status | Approved | |
|---|---|---|---|
| 🇺🇸 | Langlara insulin glargine-aldy | Approved | 2026-04-29 |
Information from official EMA, FDA, Federal Register and SEC records. Dates marked company-announced come from the company's own SEC filing; dates marked estimate are calculated, not official. Not investment or medical advice; always confirm on the source.